NCCN Expands Cancer Genetic Risk Assessment Guidelines - Medscape
Nov 20, 2024 · Updates to two genetic risk assessment guidelines now include prostate, endometrial, and gastric cancer to reflect the growing understanding of hereditary cancer risk and value of genetic …
Breast Cancer Guidelines Compared: ESMO vs NCCN - Medscape
Apr 9, 2015 · A comparison of breast cancer guidelines from two of the world's most prominent oncology organizations, the National Comprehensive Cancer Network (NCCN) and the European Society of …
Deaths From Prostate Cancer vs Other Causes: Long-Term Data
Jul 30, 2025 · The study estimated long-term outcomes over up to 30 years in men who received treatment for nonmetastatic prostate cancer that was in line with current National Comprehensive …
Adult Cancer Pain: Part 2 -- The Latest Guidelines for Pain ... - Medscape
Dec 6, 2010 · The NCCN uses the US Food and Drug Administration (FDA) definitions for these characteristics. Opioid tolerant: patients who are taking, for 1 week or longer, at least: 60 mg oral …
NCCN Recommends Only One Genomic Test for Breast Cancer
Mar 12, 2015 · HOLLYWOOD, Florida — The National Comprehensive Cancer Network (NCCN) only endorses one genomic test for use in patients with early-stage breast cancer, according to a …
Medscape | NCCN Templates™ - Publication Information
May 14, 2010 · NCCN Chemotherapy Order Templates (NCCN Templates™) NCCN is developing a library of chemotherapy order templates to improve the safe and effective use of drugs and biologics …
2025 Guidelines: Management of Differentiated Thyroid Cancer
Sep 26, 2025 · Drs Kaniksha Desai and Julie Ann Sosa discuss the 2025 American Thyroid Association guidelines for the management of differentiated thyroid cancer.
FDA Okays AI-Based Prostate Cancer Risk-Stratification Tool
Aug 14, 2025 · The NCCN Guideline states that use of the tool for risk stratification of localized prostate cancer in clinical practice is supported by solid evidence. The Category 2A recommendation signifies ...
Cancer Surveillance Guidelines Lack Clarity - Medscape
A review of National Comprehensive Cancer Network (NCCN) guidelines found that most surveillance recommendations were based on low-level evidence and often ambiguous about frequency, …
How Many Patients in Cancer Trials Get Drugs Later Approved?
Mar 7, 2025 · This proportion increased to 1 in 5 when considering National Comprehensive Cancer Network (NCCN) off-label recommendations and decreased to about 1 in 11 for approved regimens …